Tanshinone IIA: a Chinese herbal ingredient for the treatment of atherosclerosis

被引:15
|
作者
Yang, Chunkun [1 ]
Mu, Yanguang [2 ]
Li, Shuanghong [3 ]
Zhang, Yang [2 ]
Liu, Xiaoyuan [3 ]
Li, Jun [1 ]
机构
[1] China Acad Chinese Med Sci, Guanganmen Hosp, Beijing, Peoples R China
[2] Weifang Peoples Hosp, Weifang, Peoples R China
[3] Weifang Hosp Tradit Chinese Med, Weifang, Peoples R China
关键词
tanshinone IIA; vascular endothelial cells; vascular smooth muscle cells; atherosclerosis; plaques; adverse drug reactions; adhesion; SMOOTH-MUSCLE-CELLS; ENDOTHELIAL PROGENITOR CELLS; NITRIC-OXIDE SYNTHASE; ESTROGEN-RECEPTOR ACTIVATION; SALVIA-MILTIORRHIZA; ATTENUATES ATHEROSCLEROSIS; CHOLESTEROL EFFLUX; INDUCED EXPRESSION; HYDROGEN-PEROXIDE; SIGNALING PATHWAY;
D O I
10.3389/fphar.2023.1321880
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Tanshinone IIA (Tan IIA) is a fat-soluble compound extracted from Salvia miltiorrhiza, which has a protective effect against atherosclerosis (AS). Tan IIA can inhibit oxidative stress and inflammatory damage of vascular endothelial cells (VECs) and improve endothelial cell dysfunction. Tan IIA also has a good protective effect on vascular smooth muscle cells (VSMCs). It can reduce vascular stenosis by inhibiting the proliferation and migration of vascular smooth muscle cells (VSMCs), and improve the stability of the fibrous cap of atherosclerotic plaque by inhibiting apoptosis and inflammation of VSMCs. In addition, Tan IIA inhibits the inflammatory response of macrophages and the formation of foam cells in atherosclerotic plaques. In summary, Tan IIA improves AS through a complex pathway. We propose to further study the specific molecular targets of Tan IIA using systems biology methods, so as to fundamentally elucidate the mechanism of Tan IIA. It is worth mentioning that there is a lack of high-quality evidence-based medical data on Tan IIA treatment of AS. We recommend that a randomized controlled clinical trial be conducted to evaluate the exact efficacy of Tan IIA in improving AS. Finally, sodium tanshinone IIA sulfonate (STS) can cause adverse drug reactions in some patients, which needs our attention.
引用
收藏
页数:16
相关论文
共 50 条
  • [21] Tanshinone IIA in Acute Promyelocytic Leukemia
    Li, Jian
    Zhang, Kaiji
    Meng, Wentong
    Yang, Yiming
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2012, 344 (04): : 283 - 288
  • [22] Role of P-glycoprotein in the intestinal absorption of tanshinone IIA, a major active ingredient in the root of Salvia miltiorrhiza Bunge
    Yu, Xi-Yong
    Lin, Shu-Guang
    Zhou, Zhi-Wei
    Chen, Xiao
    Liang, Jun
    Liu, Pei-Qing
    Duan, Wei
    Chowbay, Balram
    Wen, Jing-Yuan
    Li, Chun-Guang
    Zhou, Shu-Feng
    CURRENT DRUG METABOLISM, 2007, 8 (04) : 325 - 340
  • [23] Determination of dihydrotanshinone I, cryptotanshinone, tanshinone I and tanshinone IIA in tanshinone ear drops by HPLC
    Liu, Gang
    Zhang, Qi-Ming
    Zhang, Jie
    Gao, Wen-Juan
    Chang, Hua
    Tan, Sheng-Jian
    Chinese Pharmaceutical Journal, 2004, 39 (03) : 218 - 220
  • [24] Tanshinone IIA attenuate atherosclerosis by mediating the crosstalk of autophagy and polarization in macrophages via miR-375
    Chen, W.
    Li, X.
    Jia, L.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1894 - 1894
  • [25] A network pharmacology approach to investigating the mechanism of Tanshinone IIA for the treatment of liver fibrosis
    Shi, Miao-Juan
    Yan, Xiu-Li
    Dong, Ben-Sheng
    Yang, Wen-Na
    Su, Shi-Bing
    Zhang, Hui
    JOURNAL OF ETHNOPHARMACOLOGY, 2020, 253
  • [26] Preparation, Characterization evaluation of Tanshinone IIA lipid microspere and comparative study of pharmacokinetics with Sodium Tanshinone IIA Sulfonate injection
    Liang, Xinli
    Zhu, Mengliang
    Cao, Yunchao
    Zhao, Guowei
    Jiang, Qieying
    Zhao, Lijun
    Liao, Zhenggen
    ADVANCES IN CHEMICAL ENGINEERING III, PTS 1-4, 2013, 781-784 : 1044 - +
  • [27] Multidirectional Intervention of Chinese Herbal Medicine in the Prevention and Treatment of Atherosclerosis: From Endothelial Protection to Immunomodulation
    Li, Jia-Ni
    Wang, Meng-Yu
    Tan, Yu-Rong
    Wang, Li-Li
    AMERICAN JOURNAL OF CHINESE MEDICINE, 2024, 52 (04): : 925 - 947
  • [28] Sodium Tanshinone IIA Sulfonate Inhibits Vascular Endothelial Cell Pyroptosis via the AMPK Signaling Pathway in Atherosclerosis
    Zhu, Ji
    Chen, Hang
    Guo, Jianan
    Zha, Chen
    Lu, Dezhao
    JOURNAL OF INFLAMMATION RESEARCH, 2022, 15 : 6293 - 6306
  • [29] Cardiovascular actions and therapeutic potential of tanshinone IIA
    Gao, Si
    Liu, Zhiping
    Li, Hong
    Little, Peter J.
    Liu, Peiqing
    Xu, Suowen
    ATHEROSCLEROSIS, 2012, 220 (01) : 3 - 10
  • [30] Cryptotanshinone but not tanshinone IIA inhibits angiogenesis in vitro
    Hur, JM
    Shim, JS
    Jung, HJ
    Kwon, HJ
    EXPERIMENTAL AND MOLECULAR MEDICINE, 2005, 37 (02): : 133 - 137